← Back to patent-cliff list
CAS 95-54-5
benzene-1,2-diamine
Codes: TELM-016, BALI-005
Application context (from source-drug indications)
HypertensionTelmisartan/Amlodipine Besylate/HydrochlorothiazideHypertensionRosuvastatin Calcium/TelmisartanHyperlipidaemiaRosuvastatin Calcium/TelmisartanUrticariaBilastineAllergic rhinitisBilastineDermatitisBilastinePruritusBilastineEczemaBilastineAllergic conjunctivitisBilastineHypertensionAmlodipine Besylate/TelmisartanHypertensionTelmisartanBreast cancerTelmisartanCardiomyopathyTelmisartanAlzheimer's diseaseTelmisartanRisk-reduction measureTelmisartanMyocardial infarctionTelmisartan
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Telmisartan/Amlodipine Besylate/Hydrochlorothiazide | Tier C — Watch / trade | - |
| Rosuvastatin Calcium/Telmisartan | Tier C — Watch / trade | - |
| Bilastine | Tier C — Watch / trade | - |
| Amlodipine Besylate/Telmisartan | Tier C — Watch / trade | - |
| Telmisartan | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole→o-cresol→4-hydroxy-3-methylbenzaldehyde→4-hydroxy-3-methyl-5-nitrobenzaldehyde→4-methoxy-3-methyl-5-nitrobenzaldehyde→benzene-1,2-diamine→2-(4-methoxy-3-methyl-5-nitrophenyl)-1-methyl-1H-benzo[d]imidazole→2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)-6-nitroaniline→methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→methyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate
1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole→o-cresol→4-hydroxy-3-methylbenzaldehyde→4-hydroxy-3-methyl-5-nitrobenzaldehyde→4-methoxy-3-methyl-5-nitrobenzaldehyde→benzene-1,2-diamine→2-(4-methoxy-3-methyl-5-nitrophenyl)-1-methyl-1H-benzo[d]imidazole→2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)-6-nitroaniline→methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→methyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate
benzene-1,2-diamine→piperidine-4-carboxylic acid→2-(piperidin-4-yl)-1H-benzo[d]imidazole→tert-butyl 4-(1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate→2-ethoxyethyl methanesulfonate→tert-butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate→1-(2-ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole→ethyl 2-methyl-2-(4-(2-((methylsulfonyl)oxy)ethyl)phenyl)propanoate→ethyl 2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoate→2-(4-bromophenyl)ethan-1-ol→((1-ethoxy-2-methylprop-1-en-1-yl)oxy)trimethylsilane→ethyl 2-(4-(2-hydroxyethyl)phenyl)-2-methylpropanoate
1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole→o-cresol→4-hydroxy-3-methylbenzaldehyde→4-hydroxy-3-methyl-5-nitrobenzaldehyde→4-methoxy-3-methyl-5-nitrobenzaldehyde→benzene-1,2-diamine→2-(4-methoxy-3-methyl-5-nitrophenyl)-1-methyl-1H-benzo[d]imidazole→2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)-6-nitroaniline→methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→methyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate
1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole→o-cresol→4-hydroxy-3-methylbenzaldehyde→4-hydroxy-3-methyl-5-nitrobenzaldehyde→4-methoxy-3-methyl-5-nitrobenzaldehyde→benzene-1,2-diamine→2-(4-methoxy-3-methyl-5-nitrophenyl)-1-methyl-1H-benzo[d]imidazole→2-methyl-4-(1-methyl-1H-benzo[d]imidazol-2-yl)-6-nitroaniline→methyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate→methyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 2-Piperidin-4-yl-1H-benzoimidazole Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Taizhou GMP-like Site | tert-butyl 4-(1H-benzo[d]iMidazol-2-yl)piperidine-1-carboxylate Pharmaceutical Intermediates | On request | On request | On request | — | |
| Qualified Partner — East China API Works | 1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole Pharmaceutical Intermediates | On request | On request | On request | — | |
| Unibest Nantong cGMP Site | 4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.